NEVADA ONCOLOGY SOCIETY (EIN 542115069) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2003

Legal Domicile

Principal Officer

MAX J COPPES

Phone

3019849496

Tax Period

2024-07-01 to 2025-06-30

NEVADA ONCOLOGY SOCIETY, founded in 2003, is a small nonprofit in the Community Improvement sector that reported $220K in total revenue in fiscal year 2024. Revenue decreased 10% compared to the prior year. Expenses of $267K exceeded revenue, resulting in a 21% operating deficit.

Mission

SEE PART III, LINE 1.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $174,000

Program Service Revenue $37,550

Investment Income $8,666

Other Revenue $0

TOTAL REVENUE $220,216

Expense Breakdown

Grants Paid $4,011

Salaries & Benefits $0

Fundraising Expenses $0

Other Expenses $263,297

TOTAL EXPENSES $267,308

Year-over-Year Comparison

	2024	2023	Change
Revenue	$220,216	$245,286	-0.1%
Expenses	$267,308	$224,157	+0.2%
Net Income	$-47,092	$21,129	-3.2%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MAX J COPPES MD PHD MBA	TRUSTEE, THEN PRES. (TRANS. 1/25)	1.00	Officer Director	$0	$0	$0
LAUREN ZION PHARMD BCOP	TR., THEN PRES-ELECT (TRANS. 1/25)	1.00	Officer Director	$0	$0	$0
ANNABEL E BARBER MD - PRES	THEN IMMED. PAST PRES (TRANS. 1/25)	1.00	Officer Director	$0	$0	$0
GUY C JONES MD	TRUSTEE, THEN TREAS. (TRANS. 1/25)	1.00	Officer Director	$0	$0	$0
LEE S SCHWARTZBERG MD FACP	SECRETARY	1.00	Officer Director	$0	$0	$0
VISHISHT MEHTA MBBS FCCP	TRUSTEE (FROM 1/25)	1.00	Director	$0	$0	$0
ANU THUMALA MD	TRUSTEE	1.00	Director	$0	$0	$0
ELIZABETH KANG PA-C DFAAPA	APP LIAISON	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$220,216	$267,308	$617,381	$-47,092
2024	No data	No data	No data	No data
2023	$190,524	$140,512	$565,821	$50,012
2022	$184,108	$130,526	$524,078	$53,582

NEVADA ONCOLOGY SOCIETY